During the past decade, Drug Trials America conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 28 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 16 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drug Trials America" #1 sponsor was "Pfizer" with 9 trials, followed by "Celgene" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Iroko Pharmaceuticals, LLC" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Trials America" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Shionogi" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Drug Trials America" are "Osteoarthritis, Knee" (6 trials), "Osteoarthritis" (5 trials), "Crohn Disease" (4 trials), "Osteoarthritis, Hip" (4 trials) and "Chronic Low Back Pain" (2 trials). Many other conditions were trialed in "Drug Trials America" in a lesser frequency.

Most popular intervention types in "Drug Trials America" are "Drug" (42 trials), "Other" (9 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Diclofenac" (3 trials), "Naproxen" (3 trials), "Ozanimod" (3 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Drug Trials America" are 47 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Drug Trials America". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Drug Trials America, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Drug Trials America, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".